Abstract:Aim To assess the clinical and radiographic outcome of partial pulpotomy by comparing MTA Angelus and Total Fill BC, as pulpotomy agents, in mature teeth with deep caries and symptoms indicative of irreversible pulpitis. Methodology The study was designed as parallel‐two arm, double blind, randomized superiority clinical trial (RCT) registered at www.clinicaltrials.gov (NCT04870398). Symptomatic mature permanent teeth with deep caries fulfilling the inclusion criteria were randomly treated using either MTA Angelus or Total Fill BC. Partial pulpotomy was performed and following complete haemostasis, the capping material was placed over the remaining pulp tissue and a postoperative periapical radiograph was taken. Clinical and radiographic follow‐up evaluation was performed for a median time of 2 years whereas levels of pain intensity were evaluated preoperatively and for 7 days after intervention using Visual Analogue Scale (VAS). For the primary outcome, (failure/success of treatment), Kaplan‐Meier survival curves for the capping materials were plotted and a log‐rank test for equality of survivor functions was applied. A multivariable random effects Cox Regression model was also applied. For the secondary outcome, (post‐operatively reported pain), a multivariable mixed effects ordinal logistic regression was structured. Results One hundred and thirty‐seven teeth in 123 patients underwent partial pulpotomy using randomly either MTA Angelus (N=74), or Total Fill BC (n=63). The percentage failure for MTA Angelus and Total Fill BC was 10.8% (8/74) and 17.5% (11/63) respectively, but the difference was not statistically significant (adjusted HR: 1.83; 95%CI: 0.68, 4.91; p= 0.23). Weak evidence was found that secondary caries involvement may impose 3.54 times greater hazard for treatment failure (adjusted HR: 3.54; 95%CI: 1.00, 12.51; p= 0.05). For each passing minute of procedural bleeding control, there was also 57% higher hazard for treatment failure (adjusted HR: 1.57; 95%CI: 0.99, 2.48; p=0.05). The odds for higher post‐operative pain were 4.73 times greater for the Total Fill BC compared to MTA Angelus (adjusted OR: 4.73; 95%CI: 2.31, 9.66; p<0.001). Conclusions Both materials exhibited similar and favorable outcome rates after partial pulpotomy in teeth with deep caries and symptoms of irreversible pulpitis. Total Fill BC was associated with higher level of postoperative pain intensities.

Effect of chlorhexidine gluconate as hemostatic agent in healing and repair after mineral trioxide aggregate vital pulp therapy in young permanent teeth – A clinical study

Direct Pulp Capping of Primary Molars with Calcium Hydroxide or MTA Following Hemorrhage Control with Different Medicaments: Randomized Clinical Trial

Mineral Trioxide Aggregate Versus Calcium Hydroxide For Pulpotomy In Primary Molars

Comparative Evaluation of Success of NeoPutty Mineral Trioxide Aggregate® with Formocresol as Pulpotomy Medicaments in Primary Molars: A Clinical Study

One-year Radiographic and Clinical Performance of Bioactive Materials in Primary Molar Pulpotomy: A Randomized Controlled Trial

Clinical and Radiographic Evaluation of Mineral Trioxide Aggregate and Human Amniotic Membrane Pulpotomy in Primary Molars: A Randomized Clinical Trial

Effectiveness of Three Agents in Pulpotomy Treatment of Permanent Molars with Incomplete Root Development: A Randomized Controlled Trial

Evaluation of Indirect Pulp Capping Using MTA, Light-cured Calcium Silicate, and Propolis in Primary Teeth: A Clinical and Radiographic Study Using VistaScan

Partial pulpotomy success in primary molars followed up for 24 months: A randomized controlled clinical trial using mineral trioxide aggregate, biodentine, and acemannan

Treatment outcome of partial pulpotomy using two different calcium silicate materials in mature permanent teeth with symptoms of irreversible pulpitis. A randomized clinical trial.

[The use of mineral trioxide aggregate for treatment of children with complications of dental trauma]

Impact of different disinfection protocols on the bond strength of NeoMTA 2 bioceramic sealer used as a root canal apical plug (in vitro study)

[Mineral Trioxide Aggragate Pulpotomy for the Treatment of Immature Permanent Teeth with Irreversible Pulpitis: a Preliminary Clinical Study].

Innovative Pulp Preservation: The Use of Platelet-Rich Fibrin (PRF) and Mineral Trioxide Aggregate (MTA) in Treating Dental Pulp Exposure

Clinical Application of Mineral Trioxide Aggregate in Young Permanent Dental Trauma

Using Mineral Trioxide Aggregate as a Pulp-Capping Material

Comparison of clinical outcomes between mineral trioxide aggregate and bioceramic materials in pulpotomy for treating early chronic pulpitis in deciduous teeth

Comparative Analysis of Antimicrobial Properties and Physical Properties of Mineral Trioxide Aggregate Mixed With Distilled Water, Chlorhexidine, and Sodium Hypochlorite Solutions: An In Vitro Study

Single-visit endodontic treatment of mature teeth with chronic apical abscesses using mineral trioxide aggregate cement: a randomized clinical trial

Discoloration after revascularization using calcium phosphosilicate-based bioceramic versus mineral trioxide aggregate in necrotic immature permanent anterior teeth: A Randomized clinical trial

Efficacy of methylene blue and curcumin mediated antimicrobial photodynamic therapy in the treatment of indirect pulp capping in permanent molar teeth